Subperiosteal Implants Constructed With Digital Technology

Subperiosteal Implants as a Treatment for Severely Atrophied Jaw in Completely and Partially Edentulous Population: A Systematic Review of Case Reports and Case Series.

Atrophied jaw is a condition where there is insufficient bone quantity to place root form implants. Several treatment plans are available for treating atrophied jaws, including subperiosteal implants. Subperiosteal implants were introduced in the last century. Poor clinical results led those implants to be progressively abandoned. Recently, several Authors suggested a revival of subperiosteal implants as an alternative to regenerative procedures.

Study Overview

• Status: Recruiting
• Conditions: Alveolar Bone Loss
• Intervention / Treatment: Other: The purpose of this systematic review of case reports and case series was to evaluate the spectrum of subperiosteal implants for severely atrophied jaws using digital technology.

Detailed Description

An electronic and manual search was conducted in the PubMed, Scopus, and Google Scholar databases. Publications of case reports and series written in English without data restrictions that reported on subperiosteal implants management of patients with severely atrophied jaws in completely and partially edentulous population.

The purpose of this systematic review of case reports and case series was to evaluate the spectrum of subperiosteal implants for severely atrophied jaws using digital technology.

• Study Type: Observational
• Enrollment (Estimated): 23

Contacts and Locations

• Study Contact: Name: Mohammed Elsawy, PhD; Phone Number: 00201061314522; Email: Dr_sawy@windowslive.com
• Study Contact Backup: Name: Salah A. Hegazy, PhD; Phone Number: 00201227690209; Email: salahhegazy@yahoo.com

Study Locations

• Egypt
  • Multiple Locations, Egypt, 12345
    • Recruiting
    • Mohammed El Sawy
    • Contact: Mohammed E Sawy, PhD; Phone Number: +201061314522; Email: Dr_sawy@windowslive.com
    • Contact: Salah A. Hegazy, PhD; Phone Number: +01227690809; Email: salahhegazy2003@yahoo.com

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: Yes

• Sampling Method: Probability Sample

Study Population

An electronic and manual search was conducted in the PubMed, Scopus, and Google Scholar databases. Publications of case reports and series written in English without data restrictions in the last 5 years.

Description

Inclusion Criteria:

• population with partial or fully edentulous arches, in particular Cawood and Howell class (IV-VI);

Exclusion Criteria:

• Articles were excluded if complex reconstructive surgery including bone grafts, barrier membranes, jaw osteotomies, sinus lift, alveolar ridge distraction, and zygomatic implants was recommended for treatment

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
to evaluate the spectrum of subperiosteal implants for severely atrophied jaws using digital technology.	The outcome was implant success or rejection.	5 year retrospective

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Biological complications	such as (dehiscence or exposure of the framework)	5 year retrospective

Other Outcome Measures

Outcome Measure	Measure Description	Time Frame
Prosthetic complications	such as (fracture of the definitive or temporary prosthesis)	5 year retrospective

Collaborators and Investigators

• Sponsor: Mansoura University
• Investigators: Principal Investigator: Mohammed ELSawy, PhD, Mansoura University

Study record dates

Study Major Dates

• Study Start (Actual): June 1, 2023
• Primary Completion (Actual): October 20, 2023
• Study Completion (Estimated): October 30, 2023

Study Registration Dates

• First Submitted: August 13, 2023
• First Submitted That Met QC Criteria: August 22, 2023
• First Posted (Actual): August 25, 2023

Study Record Updates

• Last Update Posted (Actual): October 23, 2023
• Last Update Submitted That Met QC Criteria: October 19, 2023
• Last Verified: October 1, 2023

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Musculoskeletal Diseases; Stomatognathic Diseases; Periodontal Diseases; Mouth Diseases; Bone Diseases; Periodontal Atrophy; Bone Resorption; Alveolar Bone Loss
• Other Study ID Numbers: A0107023RP

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO
• IPD Plan Description: just by contacting the corresponding author

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No